AMBALAL SARABHAI ENTERPRISES
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 2.32 | 0.64 | 0.74 | 1.49 | 6.16 |
| CEPS(Rs) | 2.84 | 1.17 | 1.21 | 1.85 | 6.46 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 20.66 | 18.27 | 17.80 | 17.08 | 15.64 |
| Tax Rate(%) | 3.80 | -2.03 | 14.59 | 24.55 | 12.87 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 5.82 | 4.27 | 4.81 | 5.04 | 12.50 |
| EBIT Margin(%) | 11.02 | 4.77 | 7.08 | 10.20 | 27.86 |
| Pre Tax Margin(%) | 8.88 | 2.40 | 3.70 | 8.65 | 26.85 |
| PAT Margin (%) | 8.54 | 2.44 | 3.16 | 6.53 | 23.39 |
| Cash Profit Margin (%) | 10.44 | 4.43 | 5.15 | 8.10 | 24.54 |
| Performance Ratios | |||||
| ROA(%) | 6.53 | 1.90 | 2.29 | 4.81 | 21.57 |
| ROE(%) | 11.94 | 3.57 | 4.25 | 9.13 | 48.74 |
| ROCE(%) | 11.52 | 5.20 | 7.16 | 11.18 | 45.53 |
| Asset Turnover(x) | 0.76 | 0.78 | 0.73 | 0.74 | 0.92 |
| Sales/Fixed Asset(x) | 1.84 | 1.85 | 1.71 | 2.02 | 2.89 |
| Working Capital/Sales(x) | 7.87 | -104.96 | 11.09 | 21.73 | 13.71 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.54 | 0.54 | 0.58 | 0.49 | 0.35 |
| Receivable days | 80.44 | 63.69 | 54.38 | 57.66 | 60.46 |
| Inventory Days | 40.16 | 36.01 | 34.09 | 33.90 | 28.13 |
| Payable days | 139.22 | 137.23 | 132.85 | 149.28 | 155.45 |
| Valuation Parameters | |||||
| PER(x) | 10.45 | 54.47 | 61.35 | 13.73 | 5.66 |
| PCE(x) | 8.55 | 30.05 | 37.66 | 11.07 | 5.40 |
| Price/Book(x) | 1.17 | 1.92 | 2.55 | 1.20 | 2.23 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.08 | 1.56 | 2.08 | 1.01 | 1.35 |
| EV/Core EBITDA(x) | 7.99 | 15.29 | 18.96 | 8.09 | 3.94 |
| EV/EBIT(x) | 9.51 | 31.76 | 28.31 | 9.65 | 4.71 |
| EV/CE(x) | 1.04 | 1.62 | 1.99 | 0.99 | 1.15 |
| M Cap / Sales | 0.92 | 1.37 | 2.01 | 0.92 | 1.36 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 3.10 | 13.03 | 1.93 | -13.45 | 20.23 |
| Core EBITDA Growth(%) | 36.56 | 5.07 | -10.80 | -68.28 | 131.58 |
| EBIT Growth(%) | 138.57 | -24.46 | -28.75 | -68.20 | 57.35 |
| PAT Growth(%) | 261.00 | -13.18 | -50.38 | -75.76 | 60.86 |
| EPS Growth(%) | 261.03 | -13.19 | -50.38 | -75.76 | 60.85 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.33 | 0.35 | 0.33 | 0.33 | 0.21 |
| Current Ratio(x) | 1.27 | 0.98 | 1.16 | 1.08 | 1.14 |
| Quick Ratio(x) | 1.04 | 0.79 | 1.00 | 0.91 | 1.00 |
| Interest Cover(x) | 5.16 | 2.01 | 2.09 | 6.60 | 27.54 |
| Total Debt/Mcap(x) | 0.28 | 0.18 | 0.13 | 0.28 | 0.10 |
Compare Financial Ratios of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹236.1 Cr | -4.5% | -6.8% | -14.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -4.5% |
-6.8% |
-14.6% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses
